dilazep has been researched along with mizoribine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hashimoto, K; Hosoya, M; Kanno, S; Kawasaki, Y; Miyazaki, K; Ono, A; Sato, M; Suyama, K; Suzuki, Y | 1 |
Hosoya, M; Kawasaki, Y; Maeda, R; Ohara, S; Suyama, K | 1 |
2 other study(ies) available for dilazep and mizoribine
Article | Year |
---|---|
Resistance factors for the treatment of immunoglobulin A nephropathy with diffuse mesangial proliferation.
Topics: Age of Onset; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Biopsy; Calgranulin A; Calgranulin B; Child; Dilazep; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Glomerulonephritis, IGA; Humans; Immunoglobulin A; Immunosuppressive Agents; Japan; Kidney Function Tests; Male; Mesangial Cells; Prednisolone; Retrospective Studies; Ribonucleosides; Risk Factors; Severity of Illness Index; Vasodilator Agents | 2014 |
Serum IgA/C3 and glomerular C3 staining predict severity of IgA nephropathy.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Biopsy; Child; Complement C3; Dilazep; Female; Glomerulonephritis, IGA; Glucocorticoids; Humans; Immunoglobulin A; Kidney Function Tests; Kidney Glomerulus; Male; Prednisolone; Prognosis; Retrospective Studies; Ribonucleosides; Vasodilator Agents; Warfarin | 2018 |